ask="5.00"
ask_size="200"
average_daily_volume="162716"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="-0.03"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="-1.66"
change_from_52_week_high="-6.33"
change_From_52_week_low="0.34"
change_in_percent="-0.88%"
close="3.39"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.18"
ebitda="0.00"
eps_estimate_current_year="-3.64"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.25"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.49"
high_52_weeks="9.72"
last_trade_date="2/28/2017"
last_trade_price="3.39"
last_trade_size="661"
last_trade_time="4:00pm"
low="3.20"
low_52_weeks="3.05"
market_capitalization="N/A"
moving_average_200_day="5.02"
moving_average_50_day="5.05"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.00"
open="3.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-32.45%"
percent_change_from_50_day_moving_average="-32.82%"
percent_change_from_52_week_high="-65.12%"
percent_change_from_52_week_low="+11.15%"
previous_close="3.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CYCC"
volume="97938"
weeks_range_52="3.05 - 9.72"
